
About Metabolus
Metabolus is a company based in San Diego (United States) founded in 2015 by William Alaynick. It operates as a B2B. The company has 33 employees. Metabolus operates in a competitive market with competitors including Lineagen, Linus Biotechnology, MARAbio, Pediatric Bioscience and SensOmics, among others.
- Headquarter San Diego, United States
- Employees 33
- Founders William Alaynick
- SectorsHealthcare
- Website metabolus.com
- Employee Count33
People of Metabolus
1 people are tracked at Metabolus (1 in leadership); the tracked headcount is 33.
| Name | Role | Group |
|---|---|---|
William Alaynick | CEO, Founder | Leadership |
Complete people profiles for Metabolus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Metabolus
Metabolus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lineagen, Linus Biotechnology, MARAbio, Pediatric Bioscience and SensOmics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lineagen.com | 2002 | Salt Lake, United States | $66.93M | 40 | Sequencing-based diagnostic tests and services for autism are provided. | |
| linusbio.com | 2020 | New York, United States | $47.65M | – | Developer of diagnostic tests for central nervous system and gastrointestinal disorders | |
| marabio.com | 2016 | Salt Lake, United States | $19.06M | – | A blood test for maternal autoantibody-related autism is developed. | |
| pediatricbioscience.com | 2006 | Sacramento, United States | $2.44M | – | Provides blood biomarker-based diagnostics for autism spectrum disorders. | |
| sensomics.com | 2007 | Toronto, Canada | – | – | Precision medicine for children's health is provided through genomic integration. | |
| neuropointdx.com | 2006 | Madison, United States | – | – | Metabolomics for neuro-developmental disorders | |
| fbbbio.com | 2020 | Coralville, United States | $401,000 | – | In-vitro diagnostic tests for COVID-19 and neurological diseases are developed. | |
| autism-biotech.com | 2011 | Belfast, United Kingdom | $51,300 | – | Develops biochemical tests for early autism diagnosis. | |
| neuraclegen.com | 2018 | Seoul, South Korea | – | – | Develops gene therapies using adeno-associated virus technology to treat various diseases. |
Detailed competitors of Metabolus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Metabolus
The website of Metabolus (metabolus.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Metabolus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Metabolus
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Metabolus
10 companies that operate in the same segment as Metabolus (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Metabolus
Metabolus was founded in 2015.
Metabolus is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
William Alaynick is the current CEO of Metabolus. They have also founded this company.
Metabolus has 33 employees.
Metabolus develops diagnostics for neurodegenerative and neuropsychiatric disorders through providing healthcare solutions, developing medical devices, offering diagnostic solutions, and neurological disorders. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Metabolus's top competitors include Linus Biotechnology, MARAbio and Lineagen.
The website of Metabolus receives about 681 thousand visits a month.